Midwest Professional Planners, Ltd. United Therapeutics Corp Transaction History

Midwest Professional Planners, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$113.81 - $129.46 $73,521 - $83,631	-646 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$101.14 - $118.31 $2,123 - $2,484	21 Added 3.36%	646 $73,000
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $6,218 - $8,812	58 Added 10.23%	625 $70,000
Q4 2017 Feb 13, 2018	BUY	$118.58 - $151.28 $67,234 - $85,775	567	567 $84,000

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Midwest Professional Planners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Midwest Professional Planners, Ltd. with notifications on news.